Not recruiting
Peripheral T-cell lymphoma unspecified
Not recruitingStudy of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Registered drugNo placebo
Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Registered drugNo placebo
- Disease:Peripheral T-cell lymphoma unspecified
- Substances:GemcitabineLacutamab+1
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Gemcitabine




